| 0 |
ADOLESCENCE |
1 |
0.5000 |
| 1 |
HIGH GRADE SEROUS OVARIAN CARCINOMA |
6 |
0.3158 |
| 2 |
SYNOVIAL SARCOMA METASTATIC |
6 |
0.2500 |
| 3 |
PARANEOPLASTIC HYPOGLYCAEMIA |
1 |
0.2000 |
| 4 |
LYMPHANGIOLEIOMYOMATOSIS |
15 |
0.1376 |
| 5 |
EWING-LIKE SARCOMA |
1 |
0.1250 |
| 6 |
CHILDHOOD |
1 |
0.1250 |
| 7 |
JEJUNECTOMY |
4 |
0.0889 |
| 8 |
LIPOSARCOMA METASTATIC |
2 |
0.0870 |
| 9 |
DESMOPLASTIC SMALL ROUND CELL TUMOUR |
7 |
0.0805 |
| 10 |
AKINAESTHESIA |
1 |
0.0714 |
| 11 |
IMPLANT SITE ULCER |
2 |
0.0690 |
| 12 |
UTERINE LEIOMYOSARCOMA |
5 |
0.0625 |
| 13 |
MEDICAL DEVICE SITE FIBROSIS |
3 |
0.0612 |
| 14 |
SOLITARY FIBROUS TUMOUR |
1 |
0.0588 |
| 15 |
FOLLICULAR DENDRITIC CELL SARCOMA |
1 |
0.0556 |
| 16 |
RETROPERITONEAL INFECTION |
1 |
0.0526 |
| 17 |
LEIOMYOSARCOMA METASTATIC |
3 |
0.0441 |
| 18 |
CEREBRAL HYGROMA |
2 |
0.0435 |
| 19 |
ENDOMETRIAL STROMAL SARCOMA |
2 |
0.0400 |
| 20 |
LEIOMYOSARCOMA RECURRENT |
1 |
0.0385 |
| 21 |
CAROTID ARTERY PERFORATION |
1 |
0.0345 |
| 22 |
INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA |
1 |
0.0345 |
| 23 |
ENZYME ACTIVITY INCREASED |
1 |
0.0312 |
| 24 |
ADMINISTRATION SITE CELLULITIS |
1 |
0.0286 |
| 25 |
CATHETER SITE DERMATITIS |
1 |
0.0278 |
| 26 |
BLOOD ACID PHOSPHATASE INCREASED |
1 |
0.0270 |
| 27 |
IMPLANT SITE THROMBOSIS |
1 |
0.0263 |
| 28 |
CYTOTOXIC CARDIOMYOPATHY |
2 |
0.0244 |
| 29 |
PRODUCT ORIGIN UNKNOWN |
1 |
0.0233 |
| 30 |
ALVEOLAR RHABDOMYOSARCOMA |
1 |
0.0227 |
| 31 |
SARCOMA METASTATIC |
3 |
0.0216 |
| 32 |
INFUSION SITE NECROSIS |
4 |
0.0208 |
| 33 |
BLOOD CREATINE PHOSPHOKINASE |
3 |
0.0205 |
| 34 |
PRODUCT LABEL COUNTERFEIT |
1 |
0.0204 |
| 35 |
SUSPECTED DRUG-INDUCED LIVER INJURY |
4 |
0.0200 |
| 36 |
BLAST CELLS PRESENT |
9 |
0.0187 |
| 37 |
MEAN CELL VOLUME ABNORMAL |
8 |
0.0169 |
| 38 |
NEUTROPHIL PERCENTAGE DECREASED |
9 |
0.0169 |
| 39 |
ANGIOSARCOMA METASTATIC |
2 |
0.0164 |
| 40 |
FOCAL PERITONITIS |
1 |
0.0161 |
| 41 |
LEIOMYOSARCOMA |
6 |
0.0156 |
| 42 |
CAPILLARY PERMEABILITY INCREASED |
1 |
0.0154 |
| 43 |
MALIGNANT FIBROUS HISTIOCYTOMA |
2 |
0.0148 |
| 44 |
CHONDROSARCOMA |
2 |
0.0127 |
| 45 |
INFECTED LYMPHOCELE |
1 |
0.0127 |
| 46 |
SCLEREMA |
1 |
0.0123 |
| 47 |
CAPILLARY LEAK SYNDROME |
25 |
0.0121 |
| 48 |
IMPLANT SITE NECROSIS |
1 |
0.0114 |
| 49 |
ADMINISTRATION SITE INFLAMMATION |
1 |
0.0111 |
| 50 |
INFUSION SITE ULCER |
1 |
0.0109 |
| 51 |
METASTASES TO THYROID |
1 |
0.0109 |
| 52 |
CATHETER SITE RELATED REACTION |
8 |
0.0107 |
| 53 |
CATHETER SITE INFLAMMATION |
6 |
0.0107 |
| 54 |
OVARIAN CANCER METASTATIC |
9 |
0.0106 |
| 55 |
PUTAMEN HAEMORRHAGE |
3 |
0.0105 |
| 56 |
HAEMOGLOBIN |
2 |
0.0101 |
| 57 |
NEUROFIBROSARCOMA |
1 |
0.0097 |
| 58 |
MEDICAL DEVICE SITE THROMBOSIS |
1 |
0.0097 |
| 59 |
MUCOCUTANEOUS TOXICITY |
1 |
0.0095 |
| 60 |
LIPOSARCOMA |
3 |
0.0094 |
| 61 |
CITROBACTER INFECTION |
4 |
0.0093 |
| 62 |
HYPERPHOSPHATASAEMIA |
1 |
0.0091 |
| 63 |
MECHANICAL ILEUS |
5 |
0.0088 |
| 64 |
BILIARY SEPSIS |
4 |
0.0086 |
| 65 |
SOFT TISSUE SARCOMA |
3 |
0.0086 |
| 66 |
NEUROMUSCULAR TOXICITY |
3 |
0.0085 |
| 67 |
CHRONIC RESPIRATORY DISEASE |
3 |
0.0085 |
| 68 |
CANCER FATIGUE |
2 |
0.0084 |
| 69 |
BRACHIOCEPHALIC VEIN THROMBOSIS |
1 |
0.0081 |
| 70 |
INADVERTENT INJECTION AIR BUBBLE |
1 |
0.0079 |
| 71 |
TRACHEOBRONCHITIS |
6 |
0.0078 |
| 72 |
COLONIC OBSTRUCTION |
2 |
0.0077 |
| 73 |
FAECAL VOMITING |
4 |
0.0075 |
| 74 |
INTRAUTERINE INFECTION |
1 |
0.0074 |
| 75 |
DUODENITIS HAEMORRHAGIC |
1 |
0.0072 |
| 76 |
HYPERMUTATION |
1 |
0.0071 |
| 77 |
IMPLANT SITE INFLAMMATION |
2 |
0.0068 |
| 78 |
BANDAEMIA |
1 |
0.0068 |
| 79 |
HAEMATOTOXICITY |
64 |
0.0067 |
| 80 |
ABSCESS SOFT TISSUE |
1 |
0.0065 |
| 81 |
HEPATOBILIARY DISEASE |
4 |
0.0064 |
| 82 |
EXTRAVASATION |
26 |
0.0063 |
| 83 |
INJECTION SITE THROMBOSIS |
2 |
0.0061 |
| 84 |
METASTASES TO RETROPERITONEUM |
1 |
0.0059 |
| 85 |
APPLICATION SITE INDURATION |
1 |
0.0059 |
| 86 |
HAEMOGLOBINAEMIA |
1 |
0.0058 |
| 87 |
APLASIA |
11 |
0.0056 |
| 88 |
METASTASES TO MUSCLE |
1 |
0.0055 |
| 89 |
RHABDOMYOSARCOMA |
1 |
0.0053 |
| 90 |
CATHETER SITE VESICLES |
1 |
0.0051 |
| 91 |
DEVICE RELATED THROMBOSIS |
5 |
0.0051 |
| 92 |
BONE MARROW TOXICITY |
6 |
0.0051 |
| 93 |
PSEUDOALDOSTERONISM |
1 |
0.0051 |
| 94 |
PRODUCT QUALITY CONTROL ISSUE |
1 |
0.0049 |
| 95 |
NASAL HERPES |
1 |
0.0049 |
| 96 |
MEAN CELL HAEMOGLOBIN DECREASED |
9 |
0.0049 |
| 97 |
ARTERIAL THROMBOSIS LIMB |
2 |
0.0048 |
| 98 |
MONONEUROPATHY |
1 |
0.0048 |
| 99 |
BLOOD BILIRUBIN ABNORMAL |
6 |
0.0047 |
| 100 |
PNEUMOCOCCAL SEPSIS |
3 |
0.0046 |
| 101 |
SEVERE ACUTE RESPIRATORY SYNDROME |
1 |
0.0045 |
| 102 |
SARCOMA |
5 |
0.0044 |
| 103 |
ANGIOSARCOMA |
2 |
0.0043 |
| 104 |
SUBILEUS |
9 |
0.0043 |
| 105 |
HYPERTRANSAMINASAEMIA |
30 |
0.0043 |
| 106 |
INTUSSUSCEPTION |
4 |
0.0042 |
| 107 |
CLOSTRIDIAL SEPSIS |
1 |
0.0041 |
| 108 |
INFECTED NEOPLASM |
1 |
0.0040 |
| 109 |
ADMINISTRATION SITE EXTRAVASATION |
4 |
0.0040 |
| 110 |
BENIGN LUNG NEOPLASM |
1 |
0.0040 |
| 111 |
TROPONIN T INCREASED |
5 |
0.0039 |
| 112 |
LEFT VENTRICULAR DILATATION |
2 |
0.0039 |
| 113 |
CHEST WALL MASS |
1 |
0.0038 |
| 114 |
NEOVASCULARISATION |
1 |
0.0038 |
| 115 |
HEART FAILURE WITH REDUCED EJECTION FRACTION |
2 |
0.0037 |
| 116 |
CATHETER SITE ERYTHEMA |
8 |
0.0037 |
| 117 |
INFUSION SITE THROMBOSIS |
1 |
0.0037 |
| 118 |
DUODENOGASTRIC REFLUX |
1 |
0.0036 |
| 119 |
RECALL PHENOMENON |
3 |
0.0036 |
| 120 |
ANAEMIA OF MALIGNANT DISEASE |
1 |
0.0036 |
| 121 |
EJECTION FRACTION |
2 |
0.0034 |
| 122 |
CATHETER SITE CELLULITIS |
1 |
0.0034 |
| 123 |
LYMPHATIC DISORDER |
2 |
0.0034 |
| 124 |
NAIL TOXICITY |
1 |
0.0033 |
| 125 |
ENTEROBACTER BACTERAEMIA |
1 |
0.0033 |
| 126 |
CREATININE URINE INCREASED |
1 |
0.0033 |
| 127 |
DEVICE INFUSION ISSUE |
8 |
0.0032 |
| 128 |
CATHETER SITE SWELLING |
3 |
0.0032 |
| 129 |
ONYCHOLYSIS |
5 |
0.0032 |
| 130 |
ARTERITIS |
2 |
0.0032 |
| 131 |
RHABDOMYOLYSIS |
132 |
0.0032 |
| 132 |
KERATOPATHY |
5 |
0.0032 |
| 133 |
OSTEITIS DEFORMANS |
1 |
0.0031 |
| 134 |
ASPERGILLOMA |
1 |
0.0031 |
| 135 |
OVARIAN CANCER RECURRENT |
5 |
0.0031 |
| 136 |
HYPERCREATINAEMIA |
1 |
0.0030 |
| 137 |
MYELOPROLIFERATIVE NEOPLASM |
2 |
0.0030 |
| 138 |
HEPATOTOXICITY |
67 |
0.0030 |
| 139 |
PARANEOPLASTIC SYNDROME |
2 |
0.0030 |
| 140 |
OESOPHAGITIS ULCERATIVE |
2 |
0.0029 |
| 141 |
RHINOCEREBRAL MUCORMYCOSIS |
1 |
0.0029 |
| 142 |
PANCYTOPENIA |
161 |
0.0029 |
| 143 |
TRANSAMINASES INCREASED |
64 |
0.0029 |
| 144 |
CIRCUMORAL OEDEMA |
1 |
0.0029 |
| 145 |
INCORRECT DRUG ADMINISTRATION RATE |
12 |
0.0028 |
| 146 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
4 |
0.0028 |
| 147 |
HYPOALBUMINAEMIA |
21 |
0.0027 |
| 148 |
ACUTE MYELOID LEUKAEMIA |
42 |
0.0027 |
| 149 |
MYOCARDIAL INJURY |
3 |
0.0027 |
| 150 |
NEUTROPENIC SEPSIS |
19 |
0.0027 |
| 151 |
RADIATION OESOPHAGITIS |
1 |
0.0026 |
| 152 |
LYMPHADENOPATHY MEDIASTINAL |
5 |
0.0026 |
| 153 |
HEPATIC MASS |
5 |
0.0026 |
| 154 |
GALLBLADDER PERFORATION |
1 |
0.0026 |
| 155 |
FEBRILE BONE MARROW APLASIA |
11 |
0.0026 |
| 156 |
IMPLANT SITE EXTRAVASATION |
2 |
0.0025 |
| 157 |
LEFT VENTRICULAR DYSFUNCTION |
17 |
0.0025 |
| 158 |
NEUTROPHILIC DERMATOSIS |
1 |
0.0025 |
| 159 |
ACUTE LEUKAEMIA |
4 |
0.0025 |
| 160 |
PERSISTENT DEPRESSIVE DISORDER |
1 |
0.0025 |
| 161 |
FEBRILE NEUTROPENIA |
163 |
0.0025 |
| 162 |
VASOPLEGIA SYNDROME |
4 |
0.0024 |
| 163 |
FISTULA OF SMALL INTESTINE |
1 |
0.0024 |
| 164 |
OVARIAN CANCER STAGE IV |
1 |
0.0024 |
| 165 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
53 |
0.0024 |
| 166 |
BLOOD PRODUCT TRANSFUSION DEPENDENT |
1 |
0.0024 |
| 167 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
68 |
0.0024 |
| 168 |
GLIOSIS |
1 |
0.0023 |
| 169 |
CATHETER SITE PAIN |
6 |
0.0023 |
| 170 |
INFUSION SITE EXTRAVASATION |
14 |
0.0022 |
| 171 |
OESOPHAGEAL INFECTION |
1 |
0.0022 |
| 172 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
2 |
0.0022 |
| 173 |
RED CELL DISTRIBUTION WIDTH INCREASED |
9 |
0.0022 |
| 174 |
PRIMARY BILIARY CHOLANGITIS |
1 |
0.0021 |
| 175 |
BONE MARROW FAILURE |
43 |
0.0021 |
| 176 |
CRANIAL NERVE PARALYSIS |
1 |
0.0021 |
| 177 |
BLOOD CREATINE ABNORMAL |
1 |
0.0021 |
| 178 |
WRONG PATIENT RECEIVED PRODUCT |
6 |
0.0020 |
| 179 |
NEUTROPHIL COUNT DECREASED |
83 |
0.0020 |
| 180 |
ALANINE AMINOTRANSFERASE INCREASED |
125 |
0.0020 |
| 181 |
METASTASES TO ABDOMINAL CAVITY |
1 |
0.0020 |
| 182 |
CARDIOTOXICITY |
18 |
0.0020 |
| 183 |
ASPARTATE AMINOTRANSFERASE INCREASED |
106 |
0.0020 |
| 184 |
DILATED CARDIOMYOPATHY |
2 |
0.0020 |
| 185 |
ACCIDENT AT HOME |
1 |
0.0019 |
| 186 |
VENOUS THROMBOSIS LIMB |
4 |
0.0019 |
| 187 |
LYMPHANGIOSIS CARCINOMATOSA |
2 |
0.0019 |
| 188 |
NEUTROPENIA |
251 |
0.0018 |
| 189 |
BRONCHOSTENOSIS |
1 |
0.0018 |
| 190 |
DEVICE RELATED INFECTION |
28 |
0.0018 |
| 191 |
THROMBOCYTOPENIA |
202 |
0.0018 |
| 192 |
AZOTAEMIA |
7 |
0.0018 |
| 193 |
TUMOUR HAEMORRHAGE |
5 |
0.0018 |
| 194 |
WOUND INFECTION STAPHYLOCOCCAL |
3 |
0.0017 |
| 195 |
HEPATIC CYTOLYSIS |
22 |
0.0017 |
| 196 |
LEUKOPENIA |
86 |
0.0017 |
| 197 |
HEPATOCELLULAR INJURY |
24 |
0.0017 |
| 198 |
JUGULAR VEIN THROMBOSIS |
3 |
0.0017 |
| 199 |
HEPATORENAL FAILURE |
1 |
0.0017 |
| 200 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
41 |
0.0016 |
| 201 |
EJECTION FRACTION DECREASED |
25 |
0.0016 |
| 202 |
MALLORY-WEISS SYNDROME |
2 |
0.0016 |
| 203 |
PHAEOCHROMOCYTOMA |
1 |
0.0015 |
| 204 |
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE |
1 |
0.0015 |
| 205 |
ILEAL PERFORATION |
1 |
0.0015 |
| 206 |
BLOOD LACTATE DEHYDROGENASE ABNORMAL |
1 |
0.0015 |
| 207 |
CARBOHYDRATE ANTIGEN 125 INCREASED |
5 |
0.0015 |
| 208 |
PLEURAL THICKENING |
1 |
0.0015 |
| 209 |
BRAIN CANCER METASTATIC |
1 |
0.0014 |
| 210 |
ANGIOPATHY |
8 |
0.0014 |
| 211 |
ACUTE PULMONARY OEDEMA |
8 |
0.0014 |
| 212 |
MUCOSAL INFLAMMATION |
37 |
0.0014 |
| 213 |
BLOOD ALBUMIN DECREASED |
11 |
0.0014 |
| 214 |
CALCULUS URETERIC |
1 |
0.0014 |
| 215 |
DRUG DELIVERY SYSTEM MALFUNCTION |
7 |
0.0014 |
| 216 |
CHOLANGITIS ACUTE |
1 |
0.0013 |
| 217 |
VASCULAR DEVICE INFECTION |
6 |
0.0013 |
| 218 |
OVARIAN NEOPLASM |
1 |
0.0013 |
| 219 |
CREATINE KINASE INCREASED |
1 |
0.0013 |
| 220 |
METASTASES TO LUNG |
15 |
0.0013 |
| 221 |
BLOOD BILIRUBIN INCREASED |
35 |
0.0013 |
| 222 |
ANURIA |
11 |
0.0013 |
| 223 |
VENOUS THROMBOSIS |
5 |
0.0013 |
| 224 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 225 |
HEPATIC FUNCTION ABNORMAL |
47 |
0.0013 |
| 226 |
ELECTROMECHANICAL DISSOCIATION |
1 |
0.0013 |
| 227 |
PNEUMONIA LEGIONELLA |
2 |
0.0012 |
| 228 |
GASTROINTESTINAL TOXICITY |
6 |
0.0012 |
| 229 |
VENTRICULAR HYPOKINESIA |
4 |
0.0012 |
| 230 |
PELVIC MASS |
1 |
0.0012 |
| 231 |
THROMBOSIS IN DEVICE |
4 |
0.0012 |
| 232 |
HYDROTHORAX |
1 |
0.0012 |
| 233 |
CONGESTIVE CARDIOMYOPATHY |
5 |
0.0012 |
| 234 |
MYOCARDIAL NECROSIS MARKER INCREASED |
2 |
0.0012 |
| 235 |
PYLORIC STENOSIS |
1 |
0.0012 |
| 236 |
NEOPLASM RECURRENCE |
4 |
0.0012 |
| 237 |
DISEASE PROGRESSION |
139 |
0.0012 |
| 238 |
PSEUDOMONAL BACTERAEMIA |
1 |
0.0012 |
| 239 |
APTYALISM |
1 |
0.0012 |
| 240 |
COLONIC ABSCESS |
1 |
0.0012 |
| 241 |
NODAL ARRHYTHMIA |
1 |
0.0012 |
| 242 |
LEFT VENTRICULAR FAILURE |
4 |
0.0012 |
| 243 |
VENTRICULAR DYSFUNCTION |
3 |
0.0012 |
| 244 |
KIDNEY FIBROSIS |
2 |
0.0012 |
| 245 |
CHOLESTASIS |
22 |
0.0011 |
| 246 |
CATHETER SITE PRURITUS |
1 |
0.0011 |
| 247 |
INTESTINAL PSEUDO-OBSTRUCTION |
1 |
0.0011 |
| 248 |
LUNG OPACITY |
3 |
0.0011 |
| 249 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
2 |
0.0011 |
| 250 |
GENERALISED OEDEMA |
14 |
0.0011 |
| 251 |
HYPERLEUKOCYTOSIS |
1 |
0.0011 |
| 252 |
BLOOD ALBUMIN INCREASED |
1 |
0.0011 |
| 253 |
ANAEMIA |
214 |
0.0011 |
| 254 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 255 |
COLOUR BLINDNESS |
1 |
0.0011 |
| 256 |
PNEUMONIA KLEBSIELLA |
2 |
0.0011 |
| 257 |
HYPOPHOSPHATAEMIA |
8 |
0.0011 |
| 258 |
BLOOD UREA ABNORMAL |
1 |
0.0011 |
| 259 |
INJECTION SITE ULCER |
1 |
0.0011 |
| 260 |
ASCITES |
31 |
0.0011 |
| 261 |
ELECTROCARDIOGRAM CHANGE |
1 |
0.0011 |
| 262 |
TROPONIN INCREASED |
8 |
0.0011 |
| 263 |
DUODENAL ULCER HAEMORRHAGE |
3 |
0.0010 |
| 264 |
PROSTATE INFECTION |
1 |
0.0010 |
| 265 |
HEPATIC FAILURE |
31 |
0.0010 |
| 266 |
DRUG ADMINISTERED IN WRONG DEVICE |
1 |
0.0010 |
| 267 |
DUODENAL PERFORATION |
1 |
0.0010 |
| 268 |
COLON ADENOMA |
1 |
0.0010 |
| 269 |
HYPERVOLAEMIA |
5 |
0.0010 |
| 270 |
CELL DEATH |
2 |
0.0010 |
| 271 |
MIXED LIVER INJURY |
3 |
0.0010 |
| 272 |
EMBOLISM VENOUS |
3 |
0.0010 |
| 273 |
DUODENITIS |
3 |
0.0010 |
| 274 |
HYPERURICAEMIA |
4 |
0.0010 |
| 275 |
BLADDER DYSFUNCTION |
1 |
0.0010 |
| 276 |
IMPLANT SITE ERYTHEMA |
1 |
0.0010 |
| 277 |
ANAL PRURITUS |
2 |
0.0010 |
| 278 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
17 |
0.0010 |
| 279 |
METASTASES TO PLEURA |
1 |
0.0010 |
| 280 |
NEOPLASM PROGRESSION |
33 |
0.0009 |
| 281 |
ALANINE AMINOTRANSFERASE ABNORMAL |
2 |
0.0009 |
| 282 |
NON-CARDIAC CHEST PAIN |
3 |
0.0009 |
| 283 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
0.0009 |
| 284 |
BLOOD SODIUM ABNORMAL |
1 |
0.0009 |
| 285 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 286 |
INFUSION SITE HAEMORRHAGE |
3 |
0.0009 |
| 287 |
OCULAR TOXICITY |
1 |
0.0009 |
| 288 |
GASTROINTESTINAL INFECTION |
8 |
0.0009 |
| 289 |
CATHETER SITE DISCHARGE |
1 |
0.0009 |
| 290 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 291 |
PNEUMONITIS |
24 |
0.0009 |
| 292 |
CARDIOMYOPATHY |
13 |
0.0009 |
| 293 |
METASTASES TO MENINGES |
2 |
0.0009 |
| 294 |
PUPILS UNEQUAL |
1 |
0.0009 |
| 295 |
SICK SINUS SYNDROME |
1 |
0.0009 |
| 296 |
PALMAR ERYTHEMA |
1 |
0.0009 |
| 297 |
OVARIAN CANCER |
8 |
0.0009 |
| 298 |
MACROCYTOSIS |
1 |
0.0009 |
| 299 |
MUCOSAL HAEMORRHAGE |
1 |
0.0009 |
| 300 |
INFUSION SITE INFECTION |
2 |
0.0009 |
| 301 |
IMPLANT SITE INFECTION |
2 |
0.0009 |
| 302 |
RESPIRATORY TRACT INFECTION VIRAL |
2 |
0.0009 |
| 303 |
ALLODYNIA |
1 |
0.0009 |
| 304 |
THROMBOPHLEBITIS |
3 |
0.0009 |
| 305 |
PROCALCITONIN INCREASED |
1 |
0.0009 |
| 306 |
PLATELET COUNT DECREASED |
90 |
0.0008 |
| 307 |
PNEUMOCYSTIS JIROVECII INFECTION |
1 |
0.0008 |
| 308 |
BILE DUCT STENOSIS |
1 |
0.0008 |
| 309 |
EMBOLISM ARTERIAL |
1 |
0.0008 |
| 310 |
MYELODYSPLASTIC SYNDROME |
12 |
0.0008 |
| 311 |
INFLAMMATORY MARKER INCREASED |
4 |
0.0008 |
| 312 |
OLIGURIA |
5 |
0.0008 |
| 313 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
1 |
0.0008 |
| 314 |
HEPATIC ENZYME ABNORMAL |
4 |
0.0008 |
| 315 |
NEUROTOXICITY |
14 |
0.0008 |
| 316 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
1 |
0.0008 |
| 317 |
METASTASES TO PERITONEUM |
2 |
0.0008 |
| 318 |
SEROMA |
1 |
0.0008 |
| 319 |
MYOCARDITIS |
9 |
0.0008 |
| 320 |
LEFT ATRIAL DILATATION |
1 |
0.0008 |
| 321 |
HEPATIC INFECTION |
1 |
0.0008 |
| 322 |
BLOOD CREATINE PHOSPHOKINASE MB INCREASED |
1 |
0.0008 |
| 323 |
ENTERITIS |
5 |
0.0008 |
| 324 |
ENDOCRINE DISORDER |
1 |
0.0008 |
| 325 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 326 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
22 |
0.0008 |
| 327 |
IATROGENIC INJURY |
1 |
0.0008 |
| 328 |
THERAPY PARTIAL RESPONDER |
12 |
0.0008 |
| 329 |
HEPATITIS TOXIC |
2 |
0.0008 |
| 330 |
PRODUCT PREPARATION ISSUE |
5 |
0.0008 |
| 331 |
BLOOD LACTIC ACID INCREASED |
4 |
0.0008 |
| 332 |
HERPES OPHTHALMIC |
1 |
0.0008 |
| 333 |
SUDDEN DEATH |
8 |
0.0008 |
| 334 |
HIRSUTISM |
1 |
0.0008 |
| 335 |
ABDOMINAL MASS |
2 |
0.0007 |
| 336 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 337 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
17 |
0.0007 |
| 338 |
DISCHARGE |
1 |
0.0007 |
| 339 |
CHOLECYSTITIS INFECTIVE |
2 |
0.0007 |
| 340 |
PRODUCT EXPIRATION DATE ISSUE |
1 |
0.0007 |
| 341 |
PERIPHERAL ARTERY THROMBOSIS |
1 |
0.0007 |
| 342 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0007 |
| 343 |
RENAL TUBULAR DISORDER |
2 |
0.0007 |
| 344 |
PRERENAL FAILURE |
1 |
0.0007 |
| 345 |
ALVEOLITIS |
1 |
0.0007 |
| 346 |
FANCONI SYNDROME |
1 |
0.0007 |
| 347 |
AUDITORY DISORDER |
1 |
0.0007 |
| 348 |
BLOOD ELECTROLYTES DECREASED |
1 |
0.0007 |
| 349 |
HAEMATOLOGICAL MALIGNANCY |
2 |
0.0007 |
| 350 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 351 |
ENTEROCOLITIS |
4 |
0.0007 |
| 352 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 353 |
TUMOUR LYSIS SYNDROME |
6 |
0.0007 |
| 354 |
ACUTE ABDOMEN |
1 |
0.0007 |
| 355 |
BACTERAEMIA |
8 |
0.0007 |
| 356 |
INFUSION SITE REACTION |
2 |
0.0007 |
| 357 |
SEPTIC SHOCK |
29 |
0.0007 |
| 358 |
INFERTILITY |
1 |
0.0007 |
| 359 |
INTERSTITIAL LUNG DISEASE |
32 |
0.0007 |
| 360 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 361 |
CONTRAINDICATION TO MEDICAL TREATMENT |
1 |
0.0007 |
| 362 |
MYOGLOBIN BLOOD INCREASED |
1 |
0.0007 |
| 363 |
ACUTE KIDNEY INJURY |
100 |
0.0007 |
| 364 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 365 |
ENCEPHALOPATHY |
16 |
0.0007 |
| 366 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 367 |
SINUS ARREST |
1 |
0.0006 |
| 368 |
FUNGAEMIA |
1 |
0.0006 |
| 369 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
1 |
0.0006 |
| 370 |
INTERMITTENT CLAUDICATION |
1 |
0.0006 |
| 371 |
ATRIAL FLUTTER |
5 |
0.0006 |
| 372 |
SEPSIS |
69 |
0.0006 |
| 373 |
WHITE BLOOD CELL COUNT DECREASED |
67 |
0.0006 |
| 374 |
CARDIOVASCULAR INSUFFICIENCY |
1 |
0.0006 |
| 375 |
MYELOSUPPRESSION |
22 |
0.0006 |
| 376 |
ASPERGILLUS INFECTION |
4 |
0.0006 |
| 377 |
ESCHERICHIA INFECTION |
5 |
0.0006 |
| 378 |
CYTOLYTIC HEPATITIS |
2 |
0.0006 |
| 379 |
PHLEBITIS |
3 |
0.0006 |
| 380 |
CARDIAC FAILURE |
47 |
0.0006 |
| 381 |
BRONCHOPNEUMONIA |
2 |
0.0006 |
| 382 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 383 |
PRODUCT COUNTERFEIT |
1 |
0.0006 |
| 384 |
HYPERBILIRUBINAEMIA |
6 |
0.0006 |
| 385 |
BLOOD CREATININE ABNORMAL |
2 |
0.0006 |
| 386 |
SKIN NECROSIS |
3 |
0.0006 |
| 387 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 388 |
EMBOLIC STROKE |
2 |
0.0006 |
| 389 |
LUNG INFILTRATION |
5 |
0.0006 |
| 390 |
SCLERODERMA |
2 |
0.0005 |
| 391 |
FOOD INTOLERANCE |
2 |
0.0005 |
| 392 |
SINUS NODE DYSFUNCTION |
1 |
0.0005 |
| 393 |
DRUG RESISTANCE |
14 |
0.0005 |
| 394 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 395 |
OTOTOXICITY |
1 |
0.0005 |
| 396 |
STREPTOCOCCAL INFECTION |
3 |
0.0005 |
| 397 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 398 |
SKIN TOXICITY |
3 |
0.0005 |
| 399 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 400 |
MALIGNANT NEOPLASM PROGRESSION |
54 |
0.0005 |
| 401 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 402 |
BILE DUCT OBSTRUCTION |
1 |
0.0005 |
| 403 |
PLEURAL EFFUSION |
32 |
0.0005 |
| 404 |
ADRENAL DISORDER |
1 |
0.0005 |
| 405 |
ACUTE HEPATIC FAILURE |
7 |
0.0005 |
| 406 |
METASTASES TO LIVER |
9 |
0.0005 |
| 407 |
BICYTOPENIA |
1 |
0.0005 |
| 408 |
HAEMATOCRIT DECREASED |
10 |
0.0005 |
| 409 |
OESOPHAGEAL CANDIDIASIS |
2 |
0.0005 |
| 410 |
SMALL INTESTINAL HAEMORRHAGE |
1 |
0.0005 |
| 411 |
LYMPHOPENIA |
7 |
0.0005 |
| 412 |
POST PROCEDURAL INFECTION |
4 |
0.0005 |
| 413 |
INJECTION SITE NECROSIS |
1 |
0.0005 |
| 414 |
LIVER INJURY |
12 |
0.0005 |
| 415 |
HEPATIC ENZYME INCREASED |
33 |
0.0005 |
| 416 |
LIVER FUNCTION TEST ABNORMAL |
14 |
0.0005 |
| 417 |
HYPERPYREXIA |
2 |
0.0005 |
| 418 |
LIVER FUNCTION TEST INCREASED |
10 |
0.0005 |
| 419 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 420 |
LYMPHOCYTOSIS |
1 |
0.0005 |
| 421 |
PERICARDIAL HAEMORRHAGE |
1 |
0.0005 |
| 422 |
HYPOKALAEMIA |
21 |
0.0005 |
| 423 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
4 |
0.0005 |
| 424 |
INTESTINAL OBSTRUCTION |
17 |
0.0005 |
| 425 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 426 |
CARDIAC FAILURE ACUTE |
3 |
0.0004 |
| 427 |
ILEUS PARALYTIC |
2 |
0.0004 |
| 428 |
DRUG-INDUCED LIVER INJURY |
14 |
0.0004 |
| 429 |
MYOSITIS |
4 |
0.0004 |
| 430 |
LARGE INTESTINAL HAEMORRHAGE |
1 |
0.0004 |
| 431 |
COLITIS ISCHAEMIC |
3 |
0.0004 |
| 432 |
URINARY TRACT DISORDER |
2 |
0.0004 |
| 433 |
GENERAL PHYSICAL CONDITION ABNORMAL |
3 |
0.0004 |
| 434 |
DISEASE RECURRENCE |
21 |
0.0004 |
| 435 |
URINE ABNORMALITY |
2 |
0.0004 |
| 436 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
31 |
0.0004 |
| 437 |
HAEMOLYTIC URAEMIC SYNDROME |
1 |
0.0004 |
| 438 |
AGRANULOCYTOSIS |
8 |
0.0004 |
| 439 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 440 |
ESCHERICHIA BACTERAEMIA |
1 |
0.0004 |
| 441 |
HYPOCALCAEMIA |
8 |
0.0004 |
| 442 |
CHOLECYSTITIS |
5 |
0.0004 |
| 443 |
CARDIOGENIC SHOCK |
6 |
0.0004 |
| 444 |
SUPRAVENTRICULAR TACHYCARDIA |
4 |
0.0004 |
| 445 |
LONG QT SYNDROME |
1 |
0.0004 |
| 446 |
ACUTE RESPIRATORY FAILURE |
8 |
0.0004 |
| 447 |
APHAGIA |
2 |
0.0004 |
| 448 |
GASTROINTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 449 |
PAINFUL RESPIRATION |
1 |
0.0004 |
| 450 |
RESPIRATORY FAILURE |
30 |
0.0004 |
| 451 |
THROMBOTIC MICROANGIOPATHY |
4 |
0.0004 |
| 452 |
HAEMORRHOIDAL HAEMORRHAGE |
2 |
0.0004 |
| 453 |
RENAL TUBULAR NECROSIS |
4 |
0.0004 |
| 454 |
ACUTE MYOCARDIAL INFARCTION |
12 |
0.0004 |
| 455 |
SMALL INTESTINAL OBSTRUCTION |
5 |
0.0004 |
| 456 |
RETINAL TEAR |
1 |
0.0004 |
| 457 |
ORGANISING PNEUMONIA |
2 |
0.0004 |
| 458 |
PULMONARY MASS |
6 |
0.0004 |
| 459 |
ILEUS |
5 |
0.0004 |
| 460 |
HYPERPARATHYROIDISM SECONDARY |
1 |
0.0004 |
| 461 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
4 |
0.0004 |
| 462 |
BLOOD CREATININE INCREASED |
26 |
0.0004 |
| 463 |
LYMPHOCYTE COUNT DECREASED |
7 |
0.0004 |
| 464 |
HAEMATEMESIS |
10 |
0.0004 |
| 465 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 466 |
CANCER PAIN |
1 |
0.0004 |
| 467 |
HYPONATRAEMIA |
22 |
0.0004 |
| 468 |
LUNG INFECTION |
6 |
0.0004 |
| 469 |
PNEUMOTHORAX |
6 |
0.0004 |
| 470 |
RENAL FAILURE |
50 |
0.0004 |
| 471 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 472 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 473 |
OESOPHAGITIS |
4 |
0.0004 |
| 474 |
EMBOLISM |
3 |
0.0004 |
| 475 |
LIVER DISORDER |
16 |
0.0004 |
| 476 |
SECOND PRIMARY MALIGNANCY |
3 |
0.0004 |
| 477 |
HYPOMAGNESAEMIA |
5 |
0.0004 |
| 478 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0004 |
| 479 |
DISSEMINATED INTRAVASCULAR COAGULATION |
5 |
0.0004 |
| 480 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
0.0004 |
| 481 |
CHOLECYSTITIS ACUTE |
2 |
0.0004 |
| 482 |
SINUS TACHYCARDIA |
5 |
0.0004 |
| 483 |
MULTI-ORGAN FAILURE |
6 |
0.0003 |
| 484 |
COMA SCALE ABNORMAL |
1 |
0.0003 |
| 485 |
METABOLIC DISORDER |
2 |
0.0003 |
| 486 |
VASCULITIS |
4 |
0.0003 |
| 487 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 488 |
PERIPHERAL SENSORY NEUROPATHY |
2 |
0.0003 |
| 489 |
LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0003 |
| 490 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
2 |
0.0003 |
| 491 |
CATARACT OPERATION |
2 |
0.0003 |
| 492 |
PULMONARY OEDEMA |
15 |
0.0003 |
| 493 |
POLYNEUROPATHY |
4 |
0.0003 |
| 494 |
HEPATITIS CHOLESTATIC |
2 |
0.0003 |
| 495 |
LEUKOCYTOSIS |
6 |
0.0003 |
| 496 |
STOMATITIS |
20 |
0.0003 |
| 497 |
UNDERDOSE |
24 |
0.0003 |
| 498 |
CYTOPENIA |
4 |
0.0003 |
| 499 |
INTRACARDIAC THROMBUS |
1 |
0.0003 |
| 500 |
LARYNGEAL OEDEMA |
2 |
0.0003 |
| 501 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 502 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 503 |
CHOLANGITIS |
2 |
0.0003 |
| 504 |
VOMITING |
151 |
0.0003 |
| 505 |
HEPATITIS B REACTIVATION |
1 |
0.0003 |
| 506 |
HAEMOGLOBIN DECREASED |
32 |
0.0003 |
| 507 |
LIVER ABSCESS |
1 |
0.0003 |
| 508 |
HEPATITIS ACUTE |
2 |
0.0003 |
| 509 |
HYPOVENTILATION |
1 |
0.0003 |
| 510 |
HEPATIC NEOPLASM |
1 |
0.0003 |
| 511 |
PULMONARY CONGESTION |
4 |
0.0003 |
| 512 |
OTITIS MEDIA |
1 |
0.0003 |
| 513 |
PEPTIC ULCER |
1 |
0.0003 |
| 514 |
PYREXIA |
103 |
0.0003 |
| 515 |
PERICARDITIS |
5 |
0.0003 |
| 516 |
RENAL IMPAIRMENT |
25 |
0.0003 |
| 517 |
DYSARTHRIA |
11 |
0.0003 |
| 518 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 519 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 520 |
LYMPHOEDEMA |
2 |
0.0003 |
| 521 |
DERMATITIS |
6 |
0.0003 |
| 522 |
ASTHENIA |
107 |
0.0003 |
| 523 |
NECROTISING FASCIITIS |
1 |
0.0003 |
| 524 |
RENAL FAILURE ACUTE |
12 |
0.0003 |
| 525 |
FACIAL PARESIS |
1 |
0.0003 |
| 526 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 527 |
RENAL DISORDER |
13 |
0.0003 |
| 528 |
COMPLICATION ASSOCIATED WITH DEVICE |
4 |
0.0003 |
| 529 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 530 |
HEPATITIS |
7 |
0.0003 |
| 531 |
AMYLASE INCREASED |
1 |
0.0003 |
| 532 |
HYPERTENSIVE CRISIS |
3 |
0.0003 |
| 533 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 534 |
RETINOPATHY |
1 |
0.0003 |
| 535 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 536 |
BLOOD SODIUM DECREASED |
5 |
0.0003 |
| 537 |
LUNG DISORDER |
13 |
0.0003 |
| 538 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 539 |
LIPASE INCREASED |
2 |
0.0003 |
| 540 |
NAUSEA |
206 |
0.0003 |
| 541 |
OESOPHAGEAL ULCER |
1 |
0.0003 |
| 542 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 543 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 544 |
OESOPHAGEAL PAIN |
1 |
0.0003 |
| 545 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 546 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 547 |
DECREASED APPETITE |
58 |
0.0002 |
| 548 |
BLOOD DISORDER |
2 |
0.0002 |
| 549 |
ATRIAL FIBRILLATION |
24 |
0.0002 |
| 550 |
SHOCK HAEMORRHAGIC |
2 |
0.0002 |
| 551 |
RECURRENT CANCER |
1 |
0.0002 |
| 552 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 553 |
ARTHRITIS BACTERIAL |
1 |
0.0002 |
| 554 |
PRODUCT PREPARATION ERROR |
5 |
0.0002 |
| 555 |
INJECTION SITE EXTRAVASATION |
3 |
0.0002 |
| 556 |
OSTEONECROSIS OF JAW |
6 |
0.0002 |
| 557 |
ACUTE CORONARY SYNDROME |
2 |
0.0002 |
| 558 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 559 |
INFUSION SITE ERYTHEMA |
2 |
0.0002 |
| 560 |
CANDIDA INFECTION |
4 |
0.0002 |
| 561 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 562 |
HEPATIC LESION |
1 |
0.0002 |
| 563 |
PYELONEPHRITIS |
2 |
0.0002 |
| 564 |
OCULAR ICTERUS |
1 |
0.0002 |
| 565 |
HYPERKALAEMIA |
8 |
0.0002 |
| 566 |
ADVERSE EVENT |
21 |
0.0002 |
| 567 |
HYPOXIA |
8 |
0.0002 |
| 568 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1 |
0.0002 |
| 569 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 570 |
DEHYDRATION |
30 |
0.0002 |
| 571 |
BRAIN NEOPLASM MALIGNANT |
1 |
0.0002 |
| 572 |
MYALGIA |
38 |
0.0002 |
| 573 |
PULMONARY EMBOLISM |
21 |
0.0002 |
| 574 |
NEUROPATHY PERIPHERAL |
21 |
0.0002 |
| 575 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 576 |
EAR DISORDER |
1 |
0.0002 |
| 577 |
UROSEPSIS |
2 |
0.0002 |
| 578 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 579 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 580 |
PERICARDIAL EFFUSION |
5 |
0.0002 |
| 581 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 582 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 583 |
DEVICE OCCLUSION |
3 |
0.0002 |
| 584 |
HEPATIC CIRRHOSIS |
4 |
0.0002 |
| 585 |
PNEUMONIA |
68 |
0.0002 |
| 586 |
PRODUCT PRESCRIBING ERROR |
5 |
0.0002 |
| 587 |
IMPAIRED QUALITY OF LIFE |
3 |
0.0002 |
| 588 |
OEDEMA PERIPHERAL |
25 |
0.0002 |
| 589 |
HAEMORRHOIDS |
4 |
0.0002 |
| 590 |
HAEMATURIA |
7 |
0.0002 |
| 591 |
HEPATOMEGALY |
2 |
0.0002 |
| 592 |
OEDEMA |
11 |
0.0002 |
| 593 |
DRUG INTERACTION |
32 |
0.0002 |
| 594 |
INJECTION SITE INFLAMMATION |
1 |
0.0002 |
| 595 |
TOXIC SKIN ERUPTION |
2 |
0.0002 |
| 596 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 597 |
FEMORAL NECK FRACTURE |
1 |
0.0002 |
| 598 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 599 |
CACHEXIA |
1 |
0.0002 |
| 600 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 601 |
CONSTIPATION |
42 |
0.0002 |
| 602 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 603 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
3 |
0.0002 |
| 604 |
RETCHING |
4 |
0.0002 |
| 605 |
ANAL FISSURE |
1 |
0.0002 |
| 606 |
GINGIVITIS |
1 |
0.0002 |
| 607 |
ABDOMINAL PAIN |
43 |
0.0002 |
| 608 |
FAECALOMA |
1 |
0.0002 |
| 609 |
GENERAL PHYSICAL HEALTH DETERIORATION |
21 |
0.0002 |
| 610 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 611 |
COAGULOPATHY |
3 |
0.0002 |
| 612 |
NECROSIS |
1 |
0.0002 |
| 613 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 614 |
PANCREATITIS ACUTE |
4 |
0.0002 |
| 615 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 616 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
| 617 |
OFF LABEL USE |
154 |
0.0002 |
| 618 |
CARDIAC FAILURE CONGESTIVE |
14 |
0.0002 |
| 619 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 620 |
UNINTENTIONAL MEDICAL DEVICE REMOVAL |
2 |
0.0002 |
| 621 |
HYPERVENTILATION |
1 |
0.0002 |
| 622 |
CARDIAC PACEMAKER INSERTION |
1 |
0.0002 |
| 623 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 624 |
RESPIRATORY DISORDER |
5 |
0.0002 |
| 625 |
TOXICITY TO VARIOUS AGENTS |
28 |
0.0002 |
| 626 |
NO THERAPEUTIC RESPONSE |
2 |
0.0002 |
| 627 |
EPILEPSY |
5 |
0.0002 |
| 628 |
SCOLIOSIS |
1 |
0.0002 |
| 629 |
PHARYNGITIS |
2 |
0.0002 |
| 630 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 631 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 632 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 633 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 634 |
PRODUCT USE ISSUE |
29 |
0.0002 |
| 635 |
PRODUCT USE IN UNAPPROVED INDICATION |
38 |
0.0002 |
| 636 |
INFECTION |
22 |
0.0002 |
| 637 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 638 |
CYTOKINE RELEASE SYNDROME |
3 |
0.0001 |
| 639 |
THERAPEUTIC RESPONSE DECREASED |
9 |
0.0001 |
| 640 |
ARRHYTHMIA |
7 |
0.0001 |
| 641 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 642 |
DRUG TOXICITY |
2 |
0.0001 |
| 643 |
MOOD ALTERED |
4 |
0.0001 |
| 644 |
ONYCHOCLASIS |
1 |
0.0001 |
| 645 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 646 |
TREATMENT FAILURE |
12 |
0.0001 |
| 647 |
ANAPHYLACTIC REACTION |
8 |
0.0001 |
| 648 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 649 |
PULMONARY HYPERTENSION |
3 |
0.0001 |
| 650 |
LARGE INTESTINE PERFORATION |
1 |
0.0001 |
| 651 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 652 |
DEVICE MALFUNCTION |
10 |
0.0001 |
| 653 |
DUODENAL ULCER |
1 |
0.0001 |
| 654 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 655 |
DIALYSIS |
2 |
0.0001 |
| 656 |
METASTASIS |
1 |
0.0001 |
| 657 |
HYPOTENSION |
28 |
0.0001 |
| 658 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 659 |
FAECES DISCOLOURED |
3 |
0.0001 |
| 660 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 661 |
DIARRHOEA |
89 |
0.0001 |
| 662 |
GASTROENTERITIS |
2 |
0.0001 |
| 663 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 664 |
THROMBOSIS |
11 |
0.0001 |
| 665 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 666 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 667 |
DRUG INTOLERANCE |
13 |
0.0001 |
| 668 |
HAEMORRHAGE INTRACRANIAL |
2 |
0.0001 |
| 669 |
EPISTAXIS |
10 |
0.0001 |
| 670 |
CARDIAC ARREST |
11 |
0.0001 |
| 671 |
PANCREATITIS |
7 |
0.0001 |
| 672 |
HYPERTHERMIA |
1 |
0.0001 |
| 673 |
FEELING HOT |
8 |
0.0001 |
| 674 |
SHOCK |
3 |
0.0001 |
| 675 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0001 |
| 676 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 677 |
FATIGUE |
101 |
0.0001 |
| 678 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 679 |
APHTHOUS ULCER |
1 |
0.0001 |
| 680 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 681 |
CYANOSIS |
2 |
0.0001 |
| 682 |
FURUNCLE |
1 |
0.0001 |
| 683 |
GINGIVAL PAIN |
1 |
0.0001 |
| 684 |
RHINITIS |
1 |
0.0001 |
| 685 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 686 |
PRESYNCOPE |
3 |
0.0001 |
| 687 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 688 |
METASTASES TO BONE |
2 |
0.0001 |
| 689 |
VENTRICULAR TACHYCARDIA |
2 |
0.0001 |
| 690 |
CELLULITIS |
6 |
0.0001 |
| 691 |
FACE OEDEMA |
2 |
0.0001 |
| 692 |
DYSPNOEA |
67 |
0.0001 |
| 693 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 694 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 695 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 696 |
URINARY TRACT INFECTION |
20 |
0.0001 |
| 697 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 698 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 699 |
SKIN SWELLING |
1 |
0.0001 |
| 700 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 701 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 702 |
INTENTIONAL PRODUCT USE ISSUE |
10 |
0.0001 |
| 703 |
GASTRITIS |
3 |
0.0001 |
| 704 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 705 |
ISCHAEMIC STROKE |
2 |
0.0001 |
| 706 |
JAUNDICE |
3 |
0.0001 |
| 707 |
PAIN OF SKIN |
3 |
0.0001 |
| 708 |
ELECTROCARDIOGRAM QT PROLONGED |
4 |
0.0001 |
| 709 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 710 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 711 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 712 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 713 |
DEEP VEIN THROMBOSIS |
7 |
0.0001 |
| 714 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 715 |
LEUKAEMIA |
1 |
0.0001 |
| 716 |
INFUSION RELATED REACTION |
7 |
0.0001 |
| 717 |
COLITIS |
4 |
0.0001 |
| 718 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 719 |
PROTEINURIA |
2 |
0.0001 |
| 720 |
MUSCULOSKELETAL DISORDER |
2 |
0.0001 |
| 721 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 722 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 723 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 724 |
CEREBROVASCULAR ACCIDENT |
17 |
0.0001 |
| 725 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 726 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 727 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 728 |
EAR DISCOMFORT |
1 |
0.0001 |
| 729 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 730 |
NERVOUS SYSTEM DISORDER |
3 |
0.0001 |
| 731 |
GASTROINTESTINAL HAEMORRHAGE |
8 |
0.0001 |
| 732 |
FOLLICULITIS |
1 |
0.0001 |
| 733 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 734 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 735 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 736 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 737 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 738 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 739 |
EYE DISORDER |
3 |
0.0001 |
| 740 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 741 |
TACHYCARDIA |
8 |
0.0001 |
| 742 |
SKIN DISORDER |
3 |
0.0001 |
| 743 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 744 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 745 |
MALNUTRITION |
1 |
0.0001 |
| 746 |
SKIN INFECTION |
1 |
0.0001 |
| 747 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 748 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 749 |
BLISTER |
5 |
0.0001 |
| 750 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 751 |
NEOPLASM |
1 |
0.0001 |
| 752 |
GASTROOESOPHAGEAL REFLUX DISEASE |
7 |
0.0001 |
| 753 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 754 |
ALOPECIA |
17 |
0.0001 |
| 755 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 756 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 757 |
CARDIAC DISORDER |
8 |
0.0001 |
| 758 |
HYPERTENSION |
18 |
0.0001 |
| 759 |
LYMPHADENOPATHY |
3 |
0.0001 |
| 760 |
DRUG DOSE OMISSION |
14 |
0.0001 |
| 761 |
ATAXIA |
1 |
0.0001 |
| 762 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 763 |
HEPATITIS C |
1 |
0.0001 |
| 764 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 765 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 766 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 767 |
DYSGEUSIA |
6 |
0.0001 |
| 768 |
HEART RATE INCREASED |
8 |
0.0001 |
| 769 |
INFLUENZA |
9 |
0.0001 |
| 770 |
CYST |
1 |
0.0001 |
| 771 |
DRUG INEFFECTIVE |
106 |
0.0001 |
| 772 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 773 |
CHRONIC KIDNEY DISEASE |
6 |
0.0001 |
| 774 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 775 |
MALAISE |
34 |
0.0001 |
| 776 |
SKIN ULCER |
2 |
0.0001 |
| 777 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 778 |
DEATH |
66 |
0.0001 |
| 779 |
DEAFNESS |
2 |
0.0001 |
| 780 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 781 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 782 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 783 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 784 |
HYPERSENSITIVITY |
14 |
0.0001 |
| 785 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 786 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 787 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 788 |
HAEMOPTYSIS |
2 |
0.0001 |
| 789 |
MASS |
1 |
0.0001 |
| 790 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 791 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 792 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 793 |
PARALYSIS |
1 |
0.0001 |
| 794 |
RECTAL HAEMORRHAGE |
3 |
0.0001 |
| 795 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 796 |
HYPOKINESIA |
1 |
0.0001 |
| 797 |
FLUID OVERLOAD |
1 |
0.0001 |
| 798 |
NEEDLE ISSUE |
2 |
0.0001 |
| 799 |
DYSPHONIA |
4 |
0.0001 |
| 800 |
CONFUSIONAL STATE |
11 |
0.0001 |
| 801 |
COLON CANCER |
1 |
0.0001 |
| 802 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 803 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 804 |
VERTIGO |
4 |
0.0001 |
| 805 |
INSURANCE ISSUE |
1 |
0.0001 |
| 806 |
DEVICE ADHESION ISSUE |
1 |
0.0001 |
| 807 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 808 |
CHEST PAIN |
12 |
0.0001 |
| 809 |
SOMNOLENCE |
13 |
0.0001 |
| 810 |
PARAESTHESIA |
10 |
0.0001 |
| 811 |
SCIATICA |
1 |
0.0001 |
| 812 |
MUSCULAR WEAKNESS |
7 |
0.0001 |
| 813 |
PRODUCT DOSE OMISSION |
4 |
0.0001 |
| 814 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 815 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 816 |
SYNCOPE |
6 |
0.0001 |
| 817 |
URINARY RETENTION |
2 |
0.0001 |
| 818 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 819 |
HEMIPARESIS |
1 |
0.0001 |
| 820 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 821 |
METRORRHAGIA |
1 |
0.0001 |
| 822 |
CHEST DISCOMFORT |
6 |
0.0001 |
| 823 |
SCAR |
1 |
0.0001 |
| 824 |
ERYTHEMA |
12 |
0.0001 |
| 825 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 826 |
ABDOMINAL PAIN UPPER |
12 |
0.0001 |
| 827 |
DELIRIUM |
2 |
0.0001 |
| 828 |
HAEMORRHAGE |
6 |
0.0001 |
| 829 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 830 |
BRADYCARDIA |
3 |
0.0001 |
| 831 |
OSTEOMYELITIS |
1 |
0.0001 |
| 832 |
MUSCLE SPASMS |
10 |
0.0001 |
| 833 |
MEDICATION ERROR |
3 |
0.0001 |
| 834 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 835 |
COUGH |
15 |
0.0001 |
| 836 |
SWELLING |
5 |
0.0001 |
| 837 |
PHOTOPHOBIA |
1 |
0.0001 |
| 838 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 839 |
FRACTURE |
1 |
0.0001 |
| 840 |
DIABETES MELLITUS |
4 |
0.0001 |
| 841 |
BLOOD PRESSURE INCREASED |
8 |
0.0001 |
| 842 |
HERPES ZOSTER |
3 |
0.0001 |
| 843 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 844 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 845 |
ERUCTATION |
1 |
0.0001 |
| 846 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 847 |
CHOKING |
1 |
0.0001 |
| 848 |
BONE PAIN |
3 |
0.0001 |
| 849 |
KIDNEY INFECTION |
1 |
0.0001 |
| 850 |
DYSPEPSIA |
5 |
0.0001 |
| 851 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 852 |
SINUS DISORDER |
1 |
0.0001 |
| 853 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 854 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 855 |
INFLUENZA LIKE ILLNESS |
4 |
0.0000 |
| 856 |
PERITONITIS |
1 |
0.0000 |
| 857 |
PRODUCT DOSE OMISSION ISSUE |
14 |
0.0000 |
| 858 |
MOUTH ULCERATION |
1 |
0.0000 |
| 859 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 860 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 861 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 862 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 863 |
NEOPLASM MALIGNANT |
3 |
0.0000 |
| 864 |
ORAL PAIN |
1 |
0.0000 |
| 865 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 866 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
9 |
0.0000 |
| 867 |
CHROMATURIA |
1 |
0.0000 |
| 868 |
TINNITUS |
2 |
0.0000 |
| 869 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 870 |
BURNING SENSATION |
3 |
0.0000 |
| 871 |
DYSPHAGIA |
4 |
0.0000 |
| 872 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 873 |
MYOCARDIAL INFARCTION |
7 |
0.0000 |
| 874 |
HOT FLUSH |
3 |
0.0000 |
| 875 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 876 |
HYPOPHAGIA |
1 |
0.0000 |
| 877 |
HOSPITALISATION |
6 |
0.0000 |
| 878 |
THERAPY CESSATION |
2 |
0.0000 |
| 879 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 880 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 881 |
BACK PAIN |
9 |
0.0000 |
| 882 |
RASH GENERALISED |
1 |
0.0000 |
| 883 |
HAEMATOMA |
1 |
0.0000 |
| 884 |
DIPLOPIA |
1 |
0.0000 |
| 885 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 886 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 887 |
PALLOR |
1 |
0.0000 |
| 888 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 889 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 890 |
SKIN LESION |
1 |
0.0000 |
| 891 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 892 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 893 |
FEELING COLD |
1 |
0.0000 |
| 894 |
WEIGHT DECREASED |
10 |
0.0000 |
| 895 |
ABDOMINAL DISCOMFORT |
6 |
0.0000 |
| 896 |
EYE PAIN |
2 |
0.0000 |
| 897 |
FLATULENCE |
2 |
0.0000 |
| 898 |
ANGINA PECTORIS |
1 |
0.0000 |
| 899 |
HYPERSOMNIA |
1 |
0.0000 |
| 900 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 901 |
PALPITATIONS |
4 |
0.0000 |
| 902 |
CHILLS |
4 |
0.0000 |
| 903 |
SURGERY |
2 |
0.0000 |
| 904 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 905 |
RENAL INJURY |
1 |
0.0000 |
| 906 |
DEVICE ISSUE |
3 |
0.0000 |
| 907 |
APHASIA |
1 |
0.0000 |
| 908 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 909 |
DISCOMFORT |
2 |
0.0000 |
| 910 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 911 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 912 |
INJECTION SITE ERYTHEMA |
4 |
0.0000 |
| 913 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 914 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 915 |
WEIGHT INCREASED |
7 |
0.0000 |
| 916 |
HIP FRACTURE |
1 |
0.0000 |
| 917 |
NIGHT SWEATS |
1 |
0.0000 |
| 918 |
RHINORRHOEA |
2 |
0.0000 |
| 919 |
PAIN |
19 |
0.0000 |
| 920 |
SWELLING FACE |
2 |
0.0000 |
| 921 |
HEADACHE |
19 |
0.0000 |
| 922 |
RASH |
13 |
0.0000 |
| 923 |
CONDITION AGGRAVATED |
9 |
0.0000 |
| 924 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 925 |
SINUSITIS |
3 |
0.0000 |
| 926 |
GASTRIC DISORDER |
1 |
0.0000 |
| 927 |
DEVICE USE ERROR |
1 |
0.0000 |
| 928 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 929 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 930 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
| 931 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 932 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 933 |
PAIN IN EXTREMITY |
8 |
0.0000 |
| 934 |
INJECTION SITE MASS |
1 |
0.0000 |
| 935 |
HALLUCINATION |
2 |
0.0000 |
| 936 |
SEIZURE |
3 |
0.0000 |
| 937 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 938 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 939 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 940 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 941 |
DIZZINESS |
12 |
0.0000 |
| 942 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 943 |
HYPERHIDROSIS |
3 |
0.0000 |
| 944 |
HYPOACUSIS |
1 |
0.0000 |
| 945 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 946 |
MENTAL DISORDER |
1 |
0.0000 |
| 947 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 948 |
DRY SKIN |
3 |
0.0000 |
| 949 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 950 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 951 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 952 |
RENAL CANCER |
1 |
0.0000 |
| 953 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 954 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 955 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 956 |
FLUID RETENTION |
1 |
0.0000 |
| 957 |
ILLNESS |
2 |
0.0000 |
| 958 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 959 |
INFLAMMATION |
1 |
0.0000 |
| 960 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 961 |
DEPRESSED MOOD |
1 |
0.0000 |
| 962 |
INSOMNIA |
5 |
0.0000 |
| 963 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 964 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 965 |
OVERDOSE |
4 |
0.0000 |
| 966 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 967 |
DEPRESSION |
4 |
0.0000 |
| 968 |
LETHARGY |
1 |
0.0000 |
| 969 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 970 |
VISION BLURRED |
2 |
0.0000 |
| 971 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 972 |
SLEEP DISORDER |
1 |
0.0000 |
| 973 |
ANXIETY |
4 |
0.0000 |
| 974 |
MOBILITY DECREASED |
1 |
0.0000 |
| 975 |
AGITATION |
1 |
0.0000 |
| 976 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 977 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 978 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 979 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 980 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 981 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 982 |
MIGRAINE |
1 |
0.0000 |
| 983 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 984 |
PRURITUS |
4 |
0.0000 |
| 985 |
FLUSHING |
1 |
0.0000 |
| 986 |
FALL |
3 |
0.0000 |
| 987 |
JOINT SWELLING |
1 |
0.0000 |
| 988 |
HYPOAESTHESIA |
1 |
0.0000 |
| 989 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 990 |
ARTHRALGIA |
2 |
0.0000 |
| 991 |
FEELING ABNORMAL |
1 |
0.0000 |